Published in Liver Transpl on January 01, 2013
Management of dysplasia in patients with inflammatory bowel disease after liver transplantation. Liver Transpl (2013) 1.08
Liver transplantation: fifty years of experience. World J Gastroenterol (2014) 0.98
Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials. Gastroenterol Res Pract (2015) 0.89
Recurrent hepatic epithelioid hemangioendothelioma after orthotopic liver transplantation. Hepatology (2014) 0.88
Post-operative imaging in liver transplantation: state-of-the-art and future perspectives. World J Gastroenterol (2014) 0.86
Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol (2014) 0.86
Keys to long-term care of the liver transplant recipient. Nat Rev Gastroenterol Hepatol (2015) 0.83
Prevention of Hepatitis B reactivation in the setting of immunosuppression. Clin Mol Hepatol (2016) 0.80
Impact of acoustic radiation force impulse imaging in clinical practice of patients after orthotopic liver transplantation. Med Sci Monit (2014) 0.79
Infections after orthotopic liver transplantation. J Clin Exp Hepatol (2014) 0.79
Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options. Osteoporos Int (2015) 0.78
Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients. Clin Gastroenterol Hepatol (2016) 0.77
Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective. J Clin Transl Hepatol (2014) 0.77
Management of viral hepatitis in liver transplant recipients. Clin Mol Hepatol (2014) 0.77
Cell-based therapies of liver diseases: age-related challenges. Clin Interv Aging (2015) 0.77
Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States. PLoS One (2015) 0.75
Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation. United European Gastroenterol J (2016) 0.75
Reply: To PMID 23281277. Liver Transpl (2013) 0.75
Calcidiol deficiency in end-stage organ failure and after solid organ transplantation: status quo. Nutrients (2013) 0.75
Imaging follow-up after liver transplantation. Br J Radiol (2016) 0.75
Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics. Stem Cells Int (2016) 0.75
Hepatobiliary quiz-6 (2013). J Clin Exp Hepatol (2013) 0.75
Successful auto-implantation of hepatic cells in lung tissue: An animal study. J Res Med Sci (2013) 0.75
De novo autoimmune hepatitis in liver transplant: State-of-the-art review. World J Gastroenterol (2016) 0.75
Management of hepatitis B virus infection after liver transplantation. World J Gastroenterol (2015) 0.75
Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). Wien Klin Wochenschr (2016) 0.75
Long-term dietary habits and interventions in solid-organ transplantation. J Heart Lung Transplant (2015) 0.75
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study. Medicine (Baltimore) (2016) 0.75
Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol (2017) 0.75
Tacrolimus-Induced Type IV Renal Tubular Acidosis following Liver Transplantation. Case Reports Hepatol (2017) 0.75
Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World J Hepatol (2017) 0.75
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much? Curr Hepatol Rep (2017) 0.75
Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients. J Clin Transl Hepatol (2017) 0.75
Alcoholic liver disease is a strong predictor of colorectal polyps in liver transplant recipients. Endosc Int Open (2017) 0.75
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2010) 6.26
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl (2014) 2.71
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology (2003) 2.64
Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology (2006) 2.26
Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups. Liver Transpl (2003) 2.23
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl (2007) 2.08
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg? Hepatology (2015) 1.87
Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet (2012) 1.82
Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl (2006) 1.81
Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol (2006) 1.74
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl (2009) 1.72
Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transpl (2007) 1.67
Kidney function: glomerular filtration rate measurement with MR renography in patients with cirrhosis. Radiology (2011) 1.66
Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology (2004) 1.65
Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A (2003) 1.64
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Hepatitis C virus and lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 1.62
Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology (2007) 1.60
Are HIV-infected patients candidates for liver transplantation? J Hepatol (2008) 1.59
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58
Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl (2007) 1.55
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol (2008) 1.55
Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria. Ann Surg (2016) 1.52
Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation (2012) 1.48
Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Infect Dis Clin North Am (2010) 1.47
Prevalence of HBV precore/core promoter variants in the United States. Hepatology (2003) 1.47
Cancer transmission from organ donors-unavoidable but low risk. Transplantation (2012) 1.46
Factors Affecting the Decision to Grant Consent for Organ Donation: A Survey of Adults in England. Transplantation (2015) 1.45
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl (2002) 1.45
Splitting livers - balancing the gain and the pain. Transpl Int (2007) 1.44
A Donation After Circulatory Death Program Has the Potential to Increase the Number of Donors After Brain Death. Crit Care Med (2016) 1.44
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42
Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure. Liver Transpl (2008) 1.40
Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation (2002) 1.35
Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry. Transplantation (2014) 1.32
Current situation of donation after circulatory death in European countries. Transpl Int (2011) 1.32
Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol (2002) 1.29
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS (2009) 1.25
Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet (2002) 1.16
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation (2003) 1.14
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology (2009) 1.11
Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. J Hepatol (2008) 1.11
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol (2002) 1.08
Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation (2011) 1.07
Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl (2003) 1.04
First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl (2003) 1.03
Weight gain and obesity after liver transplantation. Transpl Int (2005) 1.02
Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.00
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology (2006) 0.99
Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies. Curr Opin Organ Transplant (2012) 0.99
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int (2008) 0.98
Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 0.98
The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation (2002) 0.98
Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl (2002) 0.97
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med (2016) 0.97
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course. Transplantation (2006) 0.96
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients. Am J Transplant (2004) 0.96
Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl (2003) 0.95
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients. Transplantation (2004) 0.95
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95
Transplantation in autoimmune liver diseases. World J Gastroenterol (2008) 0.94
Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients. Transplantation (2005) 0.92
Liver transplant donor candidates: associations between vascular and biliary anatomic variants. Liver Transpl (2004) 0.92
Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis. Hepatology (2002) 0.92
Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients. Liver Transpl (2014) 0.92
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology (2002) 0.92
Tobacco smoking and solid organ transplantation. Transplantation (2012) 0.92
Maribavir: a novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother (2008) 0.91
Late acute liver allograft rejection; a study of its natural history and graft survival in the current era. Transplantation (2013) 0.91
Reducing the risks of cardiovascular disease in liver allograft recipients. Transplantation (2007) 0.90
Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int (2008) 0.90
Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Radiology (2004) 0.89
Outcome of acute liver failure in the elderly. Liver Transpl (2009) 0.87
Prediction of survival for patients with fulminant hepatic failure. Hepatology (2005) 0.87
The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol (2009) 0.86
Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transpl (2006) 0.86
Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology (2002) 0.86
Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era? Am J Gastroenterol (2013) 0.86
Late protocol liver biopsies in the liver allograft: a neglected investigation? Liver Transpl (2009) 0.86
Hepatitis C virus and nonliver solid organ transplantation. Transplantation (2013) 0.86
A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl (2009) 0.85
Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation. J Am Soc Echocardiogr (2008) 0.85
Nutritional markers in liver allograft recipients. Transplantation (2005) 0.84
What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study. BMJ Open (2013) 0.84
Liver abnormalities in pregnancy. Best Pract Res Clin Gastroenterol (2013) 0.84
Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus. Gastroenterology (2004) 0.84
Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol (2011) 0.84
Liver transplantation for primary biliary cirrhosis. Clin Liver Dis (2003) 0.83
Alternative medicines and the liver. Liver Int (2003) 0.83